Eligible patients undergo breast and colorectal cancer screenings at nearly four times the rate of recommended lung cancer screening, revealing significant intervention opportunities, according to a new JAMA study.
A novel machine learning model may outperform standard statistical models in identifying and stratifying allogeneic hematopoietic cell transplantation risk among patients with myelofibrosis.
March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.
In a Dutch noninferiority phase III trial (SANO) reported in The Lancet Oncology, van der Wilk et al found that active surveillance was noninferior to standard surgery in terms of 2-year overall survi...
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
The FDA approved Qfitlia (fitusiran) for hemophilia A or B prophylaxis in patients aged 12 and older, offering reduced bleeding rates with bi-monthly dosing.